ASweetLife – JDRF Type 1 Diabetes Research Updates: What You Need to Know
Updates on islet encapsulation, the artificial pancreas project, Type I prevention and much more.
Featured
Headlines
CNN Health – The link between fat and cancer
You likely know that being overweight increases your risk for cardiovascular disease and diabetes. But did you know it also increases your risk for cancer?
DiabetesInControl – No Mortality Reduction in Type 2 Diabetes with Tight Glycemic Control
Over 10 years, patients were followed in ADVANCE-ON, a post-trial follow-up study. No adverse or protective effect was seen whether their blood sugar was tightly controlled or not. However, strict blood pressure control did reduce cardiovascular and overall mortality during the trial.
WebMD – Your Questions About the Flu Vaccine
If you’re over 6 months old, the CDC says yes, you need to get a flu vaccination at the start of every flu season. Despite the fact that we tend to label any illness that makes us sneeze, shiver, or vomit as “the flu,” true influenza isn’t a trivial illness. It can do far worse […]
Exercise May Not Reduce TII Risk as Much in People with Increased Genetic Risk
Yann C. Klimentidis, PhD, of the University of Arizona Mel and Enid Zuckerman College of Public Health in Tucson, and colleagues wrote, “It has been well established that physical activity reduces type 2 diabetes risk. However, the extent of protection afforded by physical activity may differ according to genetic factors.”
medGadget – Glooko MeterSync Blue Wirelessly Connects Many Glucometers to Smartphones (VIDEO)
Glooko (Palo Alto, CA) just released its MeterSync Blue device that connects over 30 different glucometers to its smartphone app via Bluetooth. Previously, Glooko provided a cable that was the interface between a blood glucose meter and a smartphone running the company’s app. The new device hopefully will make tracking and sharing of blood glucose […]
Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Study results showed that patients on insulin pumps had a 29% reduction in mortality rate compared to patients on multiple daily insulin injection. Patients on insulin pumps had 43% lower risk of fatal cardiovascular disease compared to those on insulin injections.
DiabetesMine – How Low-Carb is Low Enough?
This week, Wil gets a direct ask on how he feels about a controversial but well-known voice in the D-Community: Dr. Richard Bernstein, who preaches ultra-low-carb lifestyle as a “solution” to diabetes management. Opinions may vary, but Wil lays it out there… Read on at your own risk!
WSJ – New Implantable Pump Could Cut Diabetes Treatments
A diabetes drug delivered continuously from a small implantable pump resulted in a marked and sustained reduction in blood sugar in patients in two studies, potentially setting the stage for a once-a-year treatment option to manage the disease.
DiabetesMine – NewsFlash: Glooko Launches Bluetooth Tool for 30+ Glucose Meters
While we’re talking about new Bluetooth-enabled diabetes tools… Yesterday Glooko, makers of the popular cable that allows users to easily download meter readings from a multitude of FDA-cleared glucose meters into their mobile device, launched something called “MeterSync Blue” that will reportedly “bluetooth-enable tens of millions of blood glucose meters worldwide” (!)
medGadget – ILUVIEN Eye Implant for Diabetic Macular Edema Finally FDA Approved
The FDA, finally, after three rejections, has given approval to pSivida‘s (Watertown, MA) ILUVIEN drug eluting eye implant for treating diabetic macular edema (DME). The device, about the length of, but much narrower than, a grain of rice (3.5 mm x 0.37 mm), is injected intravitreally using a syringe-like device.
DiabetesMine – Accu-Chek Aviva Expert: Meter with the Mind of a Pump
When new diabetes products are launched, we’re always happy to offer some personal perspective into what it’s really like to use them in the real world. Today, our correspondent Wil Dubois offers some insight on the new Roche Accu-Chek Aviva Expert meter that was FDA-approved about a year ago, and just recently in mid-September became […]
DiabetesMine – Around the Diabetes Blogosphere: September 2014 Edition
After a busy summer in the Diabetes Community, we find ourselves transitioning into Fall with just as much activity online! Indeed, the diabetes blogosphere is bristling full of great posts that are just as diverse and beautiful as the changing colors of Fall foliage. Here’s a look at some of our fave posts from September, […]
InsulinNation – Why Lantus is Dominant Right Now
For many people with Type 1 diabetes, Lantus has been a godsend, a long-acting, slow-release basal insulin that has helped thousands of people achieve better glycemic control. Since Lantus hit the market at the turn of the 21st century, it has also become a goldmine for its parent company, Sanofi, racking up nearly $8 billion […]
FDA Approves Eyla: A New Eye Drug for Diabetic Patients
The decision was made based on two phase 3 clinical trials. These trials included 862 patients and compared Eylea 2 mg given every month, given every two months after five initial monthly injection, and macular laser photocoagulation. In both trials, Eylea demonstrated a significant improvement in diabetic retinopathy in patients with DME after two years […]
FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Dulaglutide is a member of the glucagon-like peptide (GLP-1) receptor agonist class, along with liraglutide, exenatide, and albiglutide. The US Food and Drug Administration (FDA) has approved dulaglutide (Trulicity) as a once a week injection for the treatment of adults with type 2 diabetes.
DiabetesHealth – Duodenum Resurfacing Procedure Improves Type 2 Diabetes Markers
A procedure designed to change how the body absorbs and processes glucose could help improve A1C numbers for those with type 2 diabetes, according to recent research.
WebMD – Weekly Diabetes Drugs: FAQs
WebMD asked two doctors and a pharmacist familiar with the new medications to answer some commonly asked questions about the weekly options.
WebMD – Obesity Isn’t Sole Cause of Type 2 Diabetes
Although the type 2 diabetes epidemic is commonly linked to being overweight or obese, excess weight isn’t the only factor driving the trend, new research suggests.
WebMD – Why Statins Might Raise Diabetes Risk
A new study shows that people prescribed statins rather than placebo medication had about a 12% greater risk of getting type 2 diabetes over a 4-year period, and also gained about half a pound in weight on average.
Other News
ACLS Class
- Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
- Health Partner
Insulin Nation
- DAJTEMU
- DAJTEMU
- DAJTEMU
- DAJTEMU
- Subcutaneous Islet Transplant Provides Safer, Efficient Path for Type 1 Cure
- Are Immune-Evasive Islet Cells the Key to a Type 1 Cure?
- Does Shingles Vaccine have T1D Side Effect?
- Tandem Closed Loop Cleared for Pediatric Patients
- Antibiotic Use Linked to Higher T1D Heart Disease Risk
- Can Companion Medical Save Medtronic Diabetes?
Type 2 Nation
- Is RPM Right for You?
- What Is RPM and How Does it Work?
- Just got my COVID Vaccine – Should you?
- Metformin and Thiazolidinediones Increase Anemia Risk
- Most People Could Reverse or Prevent their Type 2 Diabetes
- Miscarriages Increase Type 2 Diabetes Risk
- Link Between Liver Disease and Insulin Resistance Points to New Treatment Path
- New Oral Drug Shows Rapid Benefits in Human Islet and Mouse Models
- Breastfeeding Lowers a Mother’s Type 2 Diabetes Risk
- Type 2 Diabetes Detectable Decades Before Onset
Google News
- Study Identifies Misfolded Protein Accumulation in Mitochondria of Type 2 Diabetes Patients - geneonline.com
- GLP-1 RAs More Effective Than Metformin for Reducing Dementia Risk in T2DM - HCPLive
- GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes, study finds - Medical Xpress
- Acadiana doctors seeing rise in teen prediabetes cases - KATC
- Forever chemicals in household objects linked to type 2 diabetes, scientists warn - The Independent
- Diabetes prevention program resumes in Linn County - KGAN
- Health Rounds: New form of type 1 diabetes identified in Black patients - TradingView
- Risk for dementia, ischemic stroke, mortality lower with GLP-1 receptor agonists in type 2 diabetes, obesity - Medical Xpress
- Music Meets Fashion supports American Diabetes Assn. in Santa Ana - Los Angeles Times
- Why orange juice can be dangerous for people with diabetes - Rolling Out
Diabetes Self Management
- What Is a Normal Blood Sugar Level?
- High Blood Sugar Symptoms: Causes, Signs, and Taking Control
- Blood Sugar Chart: What’s the Normal Range for Blood Sugar?
- This Week in Diabetes News
- Baked Cod With Tomatoes and Olives
- Broccoli & Cauliflower Stir-Fry
- Sirloin Steak Antipasto Salad
- Pork and Plum Kabobs
- Grilled Chicken With Corn and Black Bean Salsa
- Grape Tomato Salad With White Beans and Cucumber
Medical News Today
- No items.
Medical Express
- GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes, study finds
- Risk for dementia, ischemic stroke, mortality lower with GLP-1 receptor agonists in type 2 diabetes, obesity
- Misfolded proteins accumulate in mitochondria of patients with type 2 diabetes, study finds
- New insights into the immune system's crucial role in wound healing
- A new diabetes subtype identified in Sub-Saharan Africa and Black Americans
- Dementia risk does not differ with GLP-1 RAs, DPP4is for seniors with type 2 diabetes, study finds
- Anti-obesity medications associated with weight rebound post-treatment
- Study links 'forever chemicals' to increased risk of type 2 diabetes
- 'Weekend warriors' with diabetes have a 33% lower risk of cardiovascular mortality, study shows
- Liver drives cancer cachexia through systemic signaling response, study finds
ScienceDaily
- This tiny implant could save diabetics from silent, deadly crashes
- Biologists identify targets for new pancreatic cancer treatments
- Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; experimental drug may help treat condition
- Can hormone therapy improve heart health in menopausal women?
- In pancreatic cancer, a race against time
- Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
- Receiving low-glucose alerts improves diabetic drivers' safety on the road
- Toward improved early detection of pancreatic cancer
- Diabetes can drive the evolution of antibiotic resistance
- New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
Clinical Trials
- Geriatric Patients Undergoing Gynaecological Cancer Surgery
- A REAL WORLD DATA COLLECTION OF HUMAN AMNIOTIC MEMBRANE(S) ON DIABETIC FOOT ULCERS, VENOUS LEG ULCERS, PRESSURE ULCERS AND POST OPERATIVE WOUNDS
- Healing of Corneal Incision After Cataract Surgery in Diabetic Patients
- Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients
- Tai Chi vs. Modified-Otago Exercises for Pain, Balance, and Motor Function in Diabetic Peripheral Neuropathy